Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Myeloma | 21 | 2024 | 5180 | 2.080 |
Why?
|
| Antibodies, Bispecific | 2 | 2023 | 164 | 0.970 |
Why?
|
| Antineoplastic Agents | 7 | 2023 | 13668 | 0.650 |
Why?
|
| Melphalan | 5 | 2022 | 431 | 0.630 |
Why?
|
| Neoplasms, Plasma Cell | 2 | 2024 | 36 | 0.430 |
Why?
|
| Phenylalanine | 3 | 2022 | 365 | 0.410 |
Why?
|
| Polycythemia | 1 | 2012 | 126 | 0.400 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 328 | 0.400 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2023 | 177 | 0.380 |
Why?
|
| B-Cell Maturation Antigen | 2 | 2023 | 140 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5442 | 0.230 |
Why?
|
| Agammaglobulinemia | 1 | 2023 | 167 | 0.210 |
Why?
|
| Dexamethasone | 4 | 2022 | 1948 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2022 | 11493 | 0.200 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2021 | 48 | 0.190 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2024 | 1269 | 0.190 |
Why?
|
| Paraproteinemias | 1 | 2023 | 247 | 0.190 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1670 | 0.180 |
Why?
|
| Transplantation, Autologous | 2 | 2022 | 2124 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 961 | 0.140 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2023 | 933 | 0.140 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 1620 | 0.110 |
Why?
|
| Antigens, CD20 | 1 | 2013 | 199 | 0.110 |
Why?
|
| New Hampshire | 1 | 2012 | 172 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2023 | 2147 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 518 | 0.100 |
Why?
|
| Humans | 26 | 2024 | 744220 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1378 | 0.100 |
Why?
|
| Immunotherapy | 2 | 2023 | 4440 | 0.090 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2016 | 1052 | 0.070 |
Why?
|
| Prognosis | 5 | 2022 | 29050 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10182 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2021 | 3747 | 0.060 |
Why?
|
| Europe | 2 | 2022 | 3339 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11007 | 0.060 |
Why?
|
| Disease Progression | 3 | 2022 | 13280 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10250 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2021 | 199 | 0.050 |
Why?
|
| Plasmacytoma | 1 | 2021 | 183 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2022 | 628 | 0.040 |
Why?
|
| Adult | 6 | 2023 | 214035 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 515 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 1102 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2021 | 591 | 0.040 |
Why?
|
| Creatinine | 1 | 2023 | 1919 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57768 | 0.040 |
Why?
|
| Middle Aged | 5 | 2023 | 213367 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9275 | 0.040 |
Why?
|
| Quality of Life | 3 | 2022 | 12805 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 1401 | 0.030 |
Why?
|
| Minority Groups | 1 | 2024 | 1223 | 0.030 |
Why?
|
| Risk Factors | 2 | 2013 | 72280 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15226 | 0.030 |
Why?
|
| Aged | 5 | 2023 | 163253 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2012 | 21752 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1531 | 0.030 |
Why?
|
| DNA Damage | 1 | 2023 | 2432 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2022 | 1582 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2751 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2023 | 2944 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2022 | 6893 | 0.020 |
Why?
|
| Base Sequence | 1 | 2023 | 12801 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2094 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2458 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77426 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8343 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4665 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7183 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 9728 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16687 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4245 | 0.020 |
Why?
|
| Male | 5 | 2023 | 350027 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 63119 | 0.020 |
Why?
|
| Palliative Care | 1 | 2021 | 3490 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5169 | 0.020 |
Why?
|
| Animals | 3 | 2022 | 168788 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8426 | 0.020 |
Why?
|
| United States | 2 | 2024 | 69867 | 0.020 |
Why?
|
| Female | 4 | 2023 | 380197 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9230 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21824 | 0.010 |
Why?
|
| Depression | 1 | 2022 | 7767 | 0.010 |
Why?
|
| Algorithms | 1 | 2023 | 13885 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8387 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40063 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 81178 | 0.010 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_